- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
BRCA1 antibody recognizes Breast cancer type 1 susceptibility protein, a chromatin-associated tumor suppressor encoded by the BRCA1 gene that functions as a central regulator of homologous recombination-mediated DNA repair and genomic stability maintenance. BRCA1 antibody, also referred to as Breast cancer susceptibility protein 1 antibody and BRCC1 antibody in the literature, is widely used in hereditary breast cancer and ovarian cancer research due to the critical role of BRCA1 in DNA double-strand break signaling, checkpoint activation, and chromatin remodeling following genotoxic stress. BRCA1 is predominantly localized within the nucleus where it forms multi-protein complexes involved in DNA damage recognition and repair pathway coordination.
BRCA1 is located on chromosome 17q21 and encodes a large multifunctional phosphoprotein containing an N-terminal RING finger domain and tandem BRCT domains near the C-terminus. These structural regions mediate interactions with numerous DNA repair and cell cycle regulatory proteins including BARD1, RAD51, PALB2, CtIP, and components of the MRN complex. Through these interactions, BRCA1 functions in homologous recombination repair, replication fork protection, chromatin ubiquitination, and maintenance of genomic integrity during DNA replication stress. Loss of BRCA1 activity results in impaired DNA repair capacity, chromosomal instability, and increased susceptibility to malignant transformation.
The BRCA1 Antibody / Hereditary Breast Cancer DNA Repair Marker format is especially relevant for studies investigating hereditary tumor syndromes, genomic instability pathways, and sensitivity to DNA damaging therapeutics. Germline BRCA1 mutations are strongly associated with hereditary breast and ovarian cancer syndromes, while somatic BRCA1 dysregulation has also been implicated in prostate cancer, pancreatic cancer, and other aggressive malignancies. Reduced BRCA1 expression or functional inactivation contributes to homologous recombination deficiency, a clinically important phenotype associated with responsiveness to PARP inhibitors and platinum-based therapies.
BRCA1 expression is commonly observed in proliferative epithelial tissues and actively cycling cell populations where ongoing DNA replication requires coordinated genomic surveillance mechanisms. Following DNA damage, BRCA1 rapidly accumulates at sites of DNA strand breaks where it participates in recruitment of repair machinery and checkpoint signaling proteins. BRCA1 also contributes to transcriptional regulation, centrosome maintenance, and chromatin organization, highlighting its broad influence on nuclear stability and cell cycle progression.
Clone BRCA1/1398 is useful for investigating nuclear BRCA1 expression patterns in cancer biology, chromatin-associated DNA repair signaling, and hereditary cancer pathway studies. Protein microarray specificity validation data further support selective target recognition for BRCA1, making this antibody valuable for applications examining homologous recombination pathways, tumor suppressor biology, and genomic maintenance mechanisms in normal and malignant tissues.
BRCA1 is part of a broader network of clinically relevant tumor suppressors and DNA repair proteins featured in our Cancer Marker Antibodies collection supporting oncology and genomic instability research.
Optimal dilution of the BRCA1 Antibody / Hereditary Breast Cancer DNA Repair Marker should be determined by the researcher.
Amino acids 445-620 were used as the immunogen for the BRCA1 antibody.
Store the BRCA1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
BRCA1 DNA repair antibody, Breast cancer susceptibility protein 1 antibody, BRCC1 antibody, BRCAI antibody, BRCA1 homologous recombination antibody, BRCA1 breast cancer marker antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.